Elimination of activated but not resting primary human CD4+ and CD8+ T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cells

This publication has 41 references indexed in Scilit:

• Cell Membrane Modification for Rapid Display of Proteins as a Novel Means of Immunomodulation
  Immunity, 2002
• Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation
  Blood, 2002
• Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma
  International Journal of Cancer, 2001
• FAS Engagement Induces the Maturation of Dendritic Cells (Dcs), the Release of Interleukin (Il)-1β, and the Production of Interferon γ in the Absence of IL-12 during Dc–T Cell Cognate Interaction
  The Journal of Experimental Medicine, 2000
• Comparative analysis of integrin expression on monocyte‐derived macrophages and monocyte‐derived dendritic cells
  Immunology, 2000
• Antigen-Specific Induction of Peripheral T Cell Tolerancein Vivoby Codelivery of DNA Vectors Encoding Antigen and Fas Ligand
  Human Gene Therapy, 2000
• Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand–deficient mice
  Journal of Clinical Investigation, 2000
• Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity
  Gene Therapy, 2000
• Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
  Nature, 1995
• Fas ligand mediates activation-induced cell death in human T lymphocytes.
  The Journal of Experimental Medicine, 1995